Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3165.26 | 1445 / 1445 | 100% | 135.52 | 183 / 183 |
liver | 100% | 5372.53 | 226 / 226 | 100% | 300.43 | 406 / 406 |
ovary | 100% | 2580.99 | 180 / 180 | 100% | 204.23 | 430 / 430 |
pancreas | 100% | 1643.20 | 328 / 328 | 100% | 181.15 | 178 / 178 |
skin | 100% | 3031.64 | 1809 / 1809 | 100% | 264.67 | 472 / 472 |
thymus | 100% | 2897.76 | 653 / 653 | 100% | 210.65 | 604 / 605 |
uterus | 100% | 2339.98 | 170 / 170 | 100% | 313.84 | 458 / 459 |
brain | 100% | 1434.23 | 2635 / 2642 | 100% | 236.41 | 705 / 705 |
intestine | 100% | 2346.49 | 966 / 966 | 99% | 285.32 | 524 / 527 |
stomach | 100% | 2111.80 | 359 / 359 | 99% | 231.70 | 284 / 286 |
prostate | 100% | 2128.83 | 245 / 245 | 99% | 234.26 | 498 / 502 |
adrenal gland | 100% | 4211.86 | 258 / 258 | 99% | 257.34 | 228 / 230 |
kidney | 100% | 3456.94 | 89 / 89 | 99% | 161.52 | 892 / 901 |
breast | 100% | 2556.63 | 459 / 459 | 99% | 265.42 | 1105 / 1118 |
bladder | 100% | 2289.24 | 21 / 21 | 99% | 278.91 | 498 / 504 |
lung | 100% | 2028.98 | 576 / 578 | 99% | 198.00 | 1143 / 1155 |
adipose | 100% | 2507.99 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 188.93 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 487.36 | 29 / 29 |
spleen | 100% | 2053.30 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 299.61 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 177.45 | 1 / 1 |
blood vessel | 100% | 2898.32 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 2109.72 | 800 / 803 | 0% | 0 | 0 / 0 |
heart | 98% | 2588.95 | 844 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 96% | 1813.93 | 890 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008209 | Biological process | androgen metabolic process |
GO_0062173 | Biological process | brexanolone metabolic process |
GO_1990180 | Biological process | mitochondrial tRNA 3'-end processing |
GO_0070901 | Biological process | mitochondrial tRNA methylation |
GO_0006550 | Biological process | isoleucine catabolic process |
GO_0006631 | Biological process | fatty acid metabolic process |
GO_0008207 | Biological process | C21-steroid hormone metabolic process |
GO_0007005 | Biological process | mitochondrion organization |
GO_0097745 | Biological process | mitochondrial tRNA 5'-end processing |
GO_0008210 | Biological process | estrogen metabolic process |
GO_0006635 | Biological process | fatty acid beta-oxidation |
GO_0006699 | Biological process | bile acid biosynthetic process |
GO_0006629 | Biological process | lipid metabolic process |
GO_0051289 | Biological process | protein homotetramerization |
GO_0005886 | Cellular component | plasma membrane |
GO_0042645 | Cellular component | mitochondrial nucleoid |
GO_0005739 | Cellular component | mitochondrion |
GO_0043527 | Cellular component | tRNA methyltransferase complex |
GO_0030678 | Cellular component | mitochondrial ribonuclease P complex |
GO_0005759 | Cellular component | mitochondrial matrix |
GO_0005737 | Cellular component | cytoplasm |
GO_0003857 | Molecular function | 3-hydroxyacyl-CoA dehydrogenase activity |
GO_0047044 | Molecular function | androstan-3-alpha,17-beta-diol dehydrogenase activity |
GO_0106283 | Molecular function | ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity |
GO_0106281 | Molecular function | chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity |
GO_0106282 | Molecular function | isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity |
GO_0047035 | Molecular function | testosterone dehydrogenase (NAD+) activity |
GO_0004303 | Molecular function | estradiol 17-beta-dehydrogenase [NAD(P)+] activity |
GO_0030283 | Molecular function | testosterone dehydrogenase [NAD(P)+] activity |
GO_0047015 | Molecular function | 3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity |
GO_0008709 | Molecular function | cholate 7-alpha-dehydrogenase activity |
GO_0044594 | Molecular function | 17-beta-hydroxysteroid dehydrogenase (NAD+) activity |
GO_0003723 | Molecular function | RNA binding |
GO_0000049 | Molecular function | tRNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | HSD17B10 |
Protein name | Hydroxysteroid 17-beta dehydrogenase 10 Epididymis secretory sperm binding protein (Hydroxysteroid dehydrogenase 10 isoform 1) Hydroxysteroid (17-beta) dehydrogenase 10 (Hydroxysteroid 17-beta dehydrogenase 10) Hydroxysteroid dehydrogenase 10 isoform 2 3-hydroxyacyl-CoA dehydrogenase type-2 (EC 1.1.1.35) (17-beta-estradiol 17-dehydrogenase) (EC 1.1.1.62) (2-methyl-3-hydroxybutyryl-CoA dehydrogenase) (MHBD) (3-alpha-(17-beta)-hydroxysteroid dehydrogenase (NAD(+))) (EC 1.1.1.239) (3-hydroxy-2-methylbutyryl-CoA dehydrogenase) (EC 1.1.1.178) (3-hydroxyacyl-CoA dehydrogenase type II) (3alpha(or 20beta)-hydroxysteroid dehydrogenase) (EC 1.1.1.53) (7-alpha-hydroxysteroid dehydrogenase) (EC 1.1.1.159) (Endoplasmic reticulum-associated amyloid beta-peptide-binding protein) (Mitochondrial ribonuclease P protein 2) (Mitochondrial RNase P protein 2) (Short chain dehydrogenase/reductase family 5C member 1) (Short-chain type dehydrogenase/reductase XH98G2) (Type II HADH) |
Synonyms | RP3-339A18.2-004 XH98G2 HADH2 MRPP2 SDR5C1 SCHAD ERAB |
Description | FUNCTION: Mitochondrial dehydrogenase involved in pathways of fatty acid, branched-chain amino acid and steroid metabolism . Acts as (S)-3-hydroxyacyl-CoA dehydrogenase in mitochondrial fatty acid beta-oxidation, a major degradation pathway of fatty acids. Catalyzes the third step in the beta-oxidation cycle, namely the reversible conversion of (S)-3-hydroxyacyl-CoA to 3-ketoacyl-CoA. Preferentially accepts straight medium- and short-chain acyl-CoA substrates with highest efficiency for (3S)-hydroxybutanoyl-CoA . Acts as 3-hydroxy-2-methylbutyryl-CoA dehydrogenase in branched-chain amino acid catabolic pathway. Catalyzes the oxidation of 3-hydroxy-2-methylbutanoyl-CoA into 2-methyl-3-oxobutanoyl-CoA, a step in isoleucine degradation pathway . Has hydroxysteroid dehydrogenase activity toward steroid hormones and bile acids. Catalyzes the oxidation of 3alpha-, 17beta-, 20beta- and 21-hydroxysteroids and 7alpha- and 7beta-hydroxy bile acids . Oxidizes allopregnanolone/brexanolone at the 3alpha-hydroxyl group, which is known to be critical for the activation of gamma-aminobutyric acid receptors (GABAARs) chloride channel . Has phospholipase C-like activity toward cardiolipin and its oxidized species. Likely oxidizes the 2'-hydroxyl in the head group of cardiolipin to form a ketone intermediate that undergoes nucleophilic attack by water and fragments into diacylglycerol, dihydroxyacetone and orthophosphate. Has higher affinity for cardiolipin with oxidized fatty acids and may degrade these species during the oxidative stress response to protect cells from apoptosis . By interacting with intracellular amyloid-beta, it may contribute to the neuronal dysfunction associated with Alzheimer disease (AD) . Essential for structural and functional integrity of mitochondria . .; FUNCTION: In addition to mitochondrial dehydrogenase activity, moonlights as a component of mitochondrial ribonuclease P, a complex that cleaves tRNA molecules in their 5'-ends . Together with TRMT10C/MRPP1, forms a subcomplex of the mitochondrial ribonuclease P, named MRPP1-MRPP2 subcomplex, which displays functions that are independent of the ribonuclease P activity . The MRPP1-MRPP2 subcomplex catalyzes the formation of N(1)-methylguanine and N(1)-methyladenine at position 9 (m1G9 and m1A9, respectively) in tRNAs; HSD17B10/MRPP2 acting as a non-catalytic subunit . The MRPP1-MRPP2 subcomplex also acts as a tRNA maturation platform: following 5'-end cleavage by the mitochondrial ribonuclease P complex, the MRPP1-MRPP2 subcomplex enhances the efficiency of 3'-processing catalyzed by ELAC2, retains the tRNA product after ELAC2 processing and presents the nascent tRNA to the mitochondrial CCA tRNA nucleotidyltransferase TRNT1 enzyme . Associates with mitochondrial DNA complexes at the nucleoids to initiate RNA processing and ribosome assembly. . |
Accessions | Q5H928 ENST00000168216.11 [Q99714-1] ENST00000375304.9 [Q99714-2] A0A804HHW5 A0A0S2Z434 A0A0S2Z410 ENST00000375298.4 Q99714 ENST00000684692.1 |